Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenfu Injection for Microcirculation in Sepsis
NCT06157320Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Dec 2023
- Primary completion
- Sep 2025
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Randomised, open-label trial of shenfu injection in sepsis (2 arms), sponsored by Ruijin Hospital. Primary endpoints: Heart Rate at Day 7, Blood Pressure at Day 7 and 4 more. Started Dec 2023; status: recruiting.
02
Drugs
shenfu injection
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT06157320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06157320.